Hartford Financial Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-502
| Closed | -$14.4K | – | 400 |
|
|
2024
Q1 | $14.4K | Hold |
502
| – | – | ﹤0.01% | 295 |
|
|
2023
Q4 | $16.5K | Hold |
502
| – | – | ﹤0.01% | 281 |
|
|
2023
Q3 | $14K | Hold |
502
| – | – | ﹤0.01% | 288 |
|
|
2023
Q2 | $17.1K | Hold |
502
| – | – | ﹤0.01% | 254 |
|
|
2023
Q1 | $15.1K | Sell |
502
-358
| -42% | -$11.1K | ﹤0.01% | 255 |
|
|
2022
Q4 | $24.3K | Sell |
860
-244
| -22% | -$7.74K | 0.01% | 241 |
|
|
2022
Q3 | $36K | Hold |
1,104
| – | – | 0.01% | 224 |
|
|
2022
Q2 | $35K | Sell |
1,104
-220
| -17% | -$7.69K | 0.01% | 221 |
|
|
2022
Q1 | $61K | Sell |
1,324
-636
| -32% | -$30.3K | 0.01% | 208 |
|
|
2021
Q4 | $120K | Hold |
1,960
| – | – | 0.03% | 169 |
|
|
2021
Q3 | $146K | Buy |
1,960
+101
| +5% | +$8.47K | 0.04% | 159 |
|
|
2021
Q2 | $172K | Hold |
1,859
| – | – | 0.04% | 151 |
|
|
2021
Q1 | $165K | Buy |
1,859
+5
| +0.3% | +$496 | 0.04% | 152 |
|
|
2020
Q4 | $173K | Hold |
1,854
| – | – | 0.05% | 150 |
|
|
2020
Q3 | $118K | Buy |
1,854
+100
| +6% | +$5.86K | 0.04% | 155 |
|
|
2020
Q2 | $91K | Hold |
1,754
| – | – | 0.03% | 169 |
|
|
2020
Q1 | $55K | Buy |
1,754
+648
| +59% | +$21.7K | 0.02% | 180 |
|
|
2019
Q4 | $37K | Hold |
1,106
| – | – | 0.01% | 229 |
|
|
2019
Q3 | $33K | Hold |
1,106
| – | – | 0.01% | 230 |
|
|
2019
Q2 | $38K | Hold |
1,106
| – | – | 0.01% | 227 |
|
|
2019
Q1 | $36K | Buy |
1,106
+4
| +0.4% | +$118 | 0.01% | 229 |
|
|
2018
Q4 | $26K | Hold |
1,102
| – | – | 0.01% | 248 |
|
|
2018
Q3 | $37K | Hold |
1,102
| – | – | 0.01% | 245 |
|
|
2018
Q2 | $32K | Hold |
1,102
| – | – | 0.01% | 254 |
|
|
2018
Q1 | $28K | Buy |
1,102
+3
| +0.3% | +$81 | 0.01% | 204 |
|
|
2017
Q4 | $26K | Hold |
1,099
| – | – | 0.01% | 206 |
|
|
2017
Q3 | $28K | Hold |
1,099
| – | – | 0.01% | 219 |
|
|
2017
Q2 | $24K | Buy |
+1,099
| New | +$22.9K | 0.01% | 222 |
|
|
2017
Q1 | – | Sell |
-1,099
| Closed | -$19K | – | 345 |
|
|
2016
Q4 | $19K | Hold |
1,099
| – | – | 0.01% | 195 |
|
|
2016
Q3 | $21K | Buy |
1,099
+157
| +17% | +$2.94K | 0.01% | 193 |
|
|
2016
Q2 | $15K | Hold |
942
| – | – | 0.01% | 191 |
|
|
2016
Q1 | $16K | Buy |
942
+487
| +107% | +$8.34K | 0.01% | 190 |
|
|
2015
Q4 | $9K | Buy |
+455
| New | +$9.04K | 0.01% | 211 |
|
Other funds holding ARKG
MMEA
Hartford Financial Management's ARKG Position: Q2 2024 in Review
Hartford Financial Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 502 shares — an estimated $14.4K sold.
Hartford Financial Management first reported a position in ARKG in Q4 2015 and held it in 33 quarters. The position peaked at $173K in Q4 2020. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.
- Hartford Financial Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
- Hartford Financial Management sold 502 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $14.4K.
- Hartford Financial Management first reported a position in ARK Genomic Revolution ETF in Q4 2015 and held it in 33 quarters.
- Hartford Financial Management's ARK Genomic Revolution ETF position peaked at $173K in Q4 2020.
- 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.
Based on Hartford Financial Management's 13F filing for Q2 2024, filed 9 Aug 2024.